166 related articles for article (PubMed ID: 11753905)
21. Albumin dialysis and Molecular Adsorbents Recirculating System (MARS) for acute Wilson's disease.
Sen S; Felldin M; Steiner C; Larsson B; Gillett GT; Olausson M; Williams R; Jalan R
Liver Transpl; 2002 Oct; 8(10):962-7. PubMed ID: 12360442
[TBL] [Abstract][Full Text] [Related]
22. Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: a prospective controlled trial.
Schmidt LE; Wang LP; Hansen BA; Larsen FS
Liver Transpl; 2003 Mar; 9(3):290-7. PubMed ID: 12619027
[TBL] [Abstract][Full Text] [Related]
23. Modification of continuous venovenous hemodiafiltration with single-pass albumin dialysate allows for removal of serum bilirubin.
Chawla LS; Georgescu F; Abell B; Seneff MG; Kimmel PL
Am J Kidney Dis; 2005 Mar; 45(3):e51-6. PubMed ID: 15754264
[TBL] [Abstract][Full Text] [Related]
24. Effective bilirubin reduction by single-pass albumin dialysis in liver failure.
Boonsrirat U; Tiranathanagul K; Srisawat N; Susantitaphong P; Komolmit P; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
Artif Organs; 2009 Aug; 33(8):648-53. PubMed ID: 19624591
[TBL] [Abstract][Full Text] [Related]
25. Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis.
Khuroo MS; Khuroo MS; Farahat KL
Liver Transpl; 2004 Sep; 10(9):1099-106. PubMed ID: 15349999
[TBL] [Abstract][Full Text] [Related]
26. Albumin dialysis without anticoagulation in high-risk patients: an observational study.
Tan HK; Yang WS; Choong HL; Wong KS
Artif Organs; 2012 Mar; 36(3):E83-8. PubMed ID: 21091517
[TBL] [Abstract][Full Text] [Related]
27. Primary nonfunction: timing retransplantation versus hemodynamic parameters and kidney function.
Novelli G; Rossi M; Poli L; Morabito V; Bussotti A; Pugliese F; Ruberto F; Novelli S; Mennini G; Berloco PB
Transplant Proc; 2008; 40(6):1854-7. PubMed ID: 18675069
[TBL] [Abstract][Full Text] [Related]
28. Molecular adsorbent recirculating system and hemostasis in patients at high risk of bleeding: an observational study.
Faybik P; Bacher A; Kozek-Langenecker SA; Steltzer H; Krenn CG; Unger S; Hetz H
Crit Care; 2006 Feb; 10(1):R24. PubMed ID: 16469128
[TBL] [Abstract][Full Text] [Related]
29. Molecular adsorbents recirculating system in patients with severe liver failure. Experience of a single Romanian centre.
Rusu EE; Voiculescu M; Zilisteanu DS; Ismail G
J Gastrointestin Liver Dis; 2009 Sep; 18(3):311-6. PubMed ID: 19795025
[TBL] [Abstract][Full Text] [Related]
30. Anticoagulation minimization is safe and effective in albumin liver dialysis using the molecular adsorbent recirculating system.
Tan HK; Yang WS; Chow P; Lui HF; Choong HL; Wong KS
Artif Organs; 2007 Mar; 31(3):193-9. PubMed ID: 17343694
[TBL] [Abstract][Full Text] [Related]
31. Molecular adsorbent recycling system in treating patients with acute liver failure: a bridge to liver transplantation.
Ding YT; Xu QX; Qiu YD; Yang YJ
Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):508-10. PubMed ID: 15567734
[TBL] [Abstract][Full Text] [Related]
32. [Clinical research of patients with acute or chronic hepatic failure treated with molecular adsorbent recirculating system].
Zhou X; Wang X; Yang Y; Zhao L; Miao J; Ding J; Fan D
Zhonghua Gan Zang Bing Za Zhi; 2002 Jun; 10(3):213-5. PubMed ID: 12113683
[TBL] [Abstract][Full Text] [Related]
33. Catholic university experience with molecular adsorbent recycling system in patients with severe liver failure.
Di Campli C; Santoro MC; Gaspari R; Merra G; Zileri Dal Verme L; Zocco MA; Piscaglia AC; Di Gioacchino G; Novi M; Santoliquido A; Flore R; Tondi P; Proietti R; Gasbarrini G; Pola P; Gasbarrini A
Transplant Proc; 2005; 37(6):2547-50. PubMed ID: 16182739
[TBL] [Abstract][Full Text] [Related]
34. Effect of extracorporeal liver support by molecular adsorbents recirculating system and Prometheus on redox state of albumin in acute-on-chronic liver failure.
Oettl K; Stadlbauer V; Krisper P; Stauber RE
Ther Apher Dial; 2009 Oct; 13(5):431-6. PubMed ID: 19788461
[TBL] [Abstract][Full Text] [Related]
35. Pro-inflammatory interleukin-18 and Caspase-1 serum levels in liver failure are unaffected by MARS treatment.
Roth GA; Faybik P; Hetz H; Hacker S; Ankersmit HJ; Bacher A; Thalhammer T; Krenn CG
Dig Liver Dis; 2009 Jun; 41(6):417-23. PubMed ID: 19019743
[TBL] [Abstract][Full Text] [Related]
36. [The treatment of molecular adsorbents recirculating system artificial liver in severe liver failure patients with multiple organ dysfunction syndrome].
Guo LM; Liu JY; Xu DZ; Li BS; Han H; Wang LH; Zhang WY; Lu LH; Guo X; Sun FX; Zhang HY; Liu XD; Zhang JP; Yao J; He ZP; Wang MM
Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):455-7. PubMed ID: 12939172
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Molecular Adsorbents Recirculating System (MARS) dialysis with combined plasma exchange and haemodialysis in children with acute liver failure.
Schaefer B; Schaefer F; Engelmann G; Meyburg J; Heckert KH; Zorn M; Schmitt CP
Nephrol Dial Transplant; 2011 Nov; 26(11):3633-9. PubMed ID: 21421589
[TBL] [Abstract][Full Text] [Related]
38. Albumin dialysis: current practice and future options.
Wauters J; Wilmer A
Liver Int; 2011 Sep; 31 Suppl 3():9-12. PubMed ID: 21824276
[TBL] [Abstract][Full Text] [Related]
39. Predicting the decrease of conjugated bilirubin with extracorporeal albumin dialysis MARS using the predialysis molar ratio of conjugated bilirubin to albumin.
Lee KH; Wendon J; Lee M; Da Costa M; Lim SG; Tan KC
Liver Transpl; 2002 Jul; 8(7):591-3. PubMed ID: 12089711
[TBL] [Abstract][Full Text] [Related]
40. Value of albumin dialysis therapy in severe liver insufficiency.
Lahdenperä A; Koivusalo AM; Vakkuri A; Höckerstedt K; Isoniemi H
Transpl Int; 2005 Jan; 17(11):717-23. PubMed ID: 15580335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
